Antinociception following 1,3,-DI-o-Tolylguanidine (DTG), a sigma ligand

R. N. Pechnick , Jeffrey S. Mogil , Wendy Faith Sternberg , B. Kest
50 ( 4) 587

1995
Studies of pain, stress, and immunity

Jeffrey S. Mogil , J. C. Liebeskind , Wendy Faith Sternberg
31

2
1993
Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay.

Bogdan Sadowski , John K. Belknap , Benjamin Kest , Jeffrey S. Mogil
Journal of Pharmacology and Experimental Therapeutics 276 ( 2) 532 -544

141
1996
Sex Differences in Supraspinal Morphine Analgesia Are Dependent on Genotype

Benjamin Kest , Jeffrey S. Mogil , Sonya G. Wilson
Journal of Pharmacology and Experimental Therapeutics 289 ( 3) 1370 -1375

139
1999
Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine (Serotonin)-1B receptors in the mediation of morphine antinociceptive sensitivity.

Jeffrey S. Mogil , Heather S. Hain , John K. Belknap
Journal of Pharmacology and Experimental Therapeutics 291 ( 2) 444 -449

36
1999
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family

Jeffrey S. Mogil , Gavril W. Pasternak
Pharmacological Reviews 53 ( 3) 381 -415

386
2001
Transgenic Studies of Pain and Analgesia: Mutation or Background Genotype?

Jeffrey S. Mogil , William R. Lariviere , Elissa J. Chesler
Journal of Pharmacology and Experimental Therapeutics 297 ( 2) 467 -473

94
2001
Imputation of Truncated p-Values For Meta-Analysis Methods and Its Genomic Application.

Jeffrey S. Mogil , William R. Lariviere , George C. Tseng , Etienne Sibille
The Annals of Applied Statistics 8 ( 4) 2150 -2174

3
2014
Identification and characterization of novel candidate compounds targeting 6- and 7-transmembrane μ-opioid receptor isoforms.

Nikolay V. Dokholyan , Nikolay V. Dokholyan , Jeffrey S. Mogil , Luda Diatchenko
British Journal of Pharmacology

2021
Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition

Kristopher T. Kahle , Jean-François Schmouth , Valérie Lavastre , Alban Latremoliere
Science Signaling 9 ( 421)

41
2016
Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications: A Systematic Review

Carole A. Federico , Taiji Wang , Adélaïde Doussau , Jeffrey S. Mogil
JAMA Internal Medicine 179 ( 1) 90 -97

11
2019
Comparing phenotypic variation between inbred and outbred mice.

Alexander H. Tuttle , Vivek M. Philip , Elissa J. Chesler , Jeffrey S. Mogil
Nature Methods 15 ( 12) 994 -996

76
2018
Sex differences in the effects of amiloride on formalin test nociception in mice.

Mona Lisa Chanda , Jeffrey S. Mogil
American Journal of Physiology-regulatory Integrative and Comparative Physiology 291 ( 2)

23
2006
Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers

Loren J. Martin , Marjo H. Piltonen , Josee Gauthier , Marino Convertino
The Journal of Pain 16 ( 12) 1321 -1333

15
2015
The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain.

Jamie K Moy , Arkady Khoutorsky , Marina N Asiedu , Bryan J Black
The Journal of Neuroscience 37 ( 31) 7481 -7499

69
2017
912
2012
Animal models of pain: progress and challenges

Jeffrey S. Mogil
Nature Reviews Neuroscience 10 ( 4) 283 -294

735
2009
Functional genomics of pain in analgesic drug development and therapy.

Torsten Arndt , Gerd Geisslinger , Alfred Ultsch , Jörn Lötsch
Pharmacology & Therapeutics 139 ( 1) 60 -70

69
2013
Sex differences in pain and analgesia: the role of gonadal hormones.

Rebecca M. Craft , Jeffrey S. Mogil , Anna Maria Aloisi
European Journal of Pain 8 ( 5) 397 -411

422
2004